<DOC>
	<DOCNO>NCT02024802</DOCNO>
	<brief_summary>There significant increase number prescription fill Custom Compounded Pain Creams . This study serve evaluate patient perception satisfaction type pain therapy allow u identify statistically relevant relationship may exist type therapy patient pain perception . A secondary goal would identify significantly relevant relationship may exist change pain perception ( ) patient overall sense well-being . The investigator ' null hypothesis great 85 % people see significant decrease perceive pain level great 85 % increase patient overall sense well .</brief_summary>
	<brief_title>Compounded Pain Creams Patient Perception</brief_title>
	<detailed_description>The purpose study evaluate level pain perceive chronic neuropathic and/or inflammatory pain patient use compounded transdermal pain cream pain management solution . Our goal identify statistically relevant relationship exist type pain therapy patient ' perceive pain level . A secondary goal study identify statistically relevant relationship change pain perception ( ) patient 's perception overall well-being . This observational study cohort observational model study design . Patients prescribe compounded pain cream regimen new pain therapy yet begin regimen recruit . We work local prescribe neurologic , orthopedic pain clinic physician identify patient begin type therapy near future . Prior administer first dose , participant need complete consent process . Participants may opt review complete informed consent form doctor member pharmacy research team . The custom survey entitle MLP-001-PC administer throughout 12 week study 4 week interval ( baseline , 4 week , 8 week , 12 week ) . Participants require come pharmacy complete subsequent survey . They mail email participant 's discretion . Any patient opts receive survey via mail email need indicate patient information form provide signature time state survey complete one 's behalf ( See Attachment 1 ) . If participant opt receive survey mail , ask return survey pharmacy either person stamp envelope provide . Participants receive survey email , need return complete survey person , mail email . We follow patient 3 6 day distribution survey remind complete return survey . Surveys complete within one week respective follow-up date exclude study respective follow-up interval . These participant still encourage complete next survey next follow-up date . The study project last one year enrollment first subject completion last subject 's participation . All result baseline follow-up survey score data compile site . Statistical analysis ( Multinomial Regressional Analysis ) perform identify statistically relevant correlation . All data summarize conclude . A description clinical trial available http : //ClinicalTrials.gov , require U.S. Law .</detailed_description>
	<mesh_term>Nociceptive Pain</mesh_term>
	<criteria>Participants must range 18 85 year age confirm state identification passport present upon completion inform consent . Participants must diagnosis indicative either Neuropathic Nociceptive Pain confirm prescribe medical provider . Participants must start new regimen transdermal ( topic ) pain therapy multiple compound reagent indicated prescription medical provider Participants must willing participate study minimum 12 week Participants must able provide write informed consent . Participants must able read understand english language Participants must prior hypersensitivity adverse event component customize prescription indicate allergy history give upon registration pharmacy . Participants must pregnant plan become pregnant within 12 week study period must breastfeed . Participants must diagnosis cancer last 5 year . Participants legally authorize representative ( LAR ) substitute participant ' write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Pain</keyword>
	<keyword>Pain Cream</keyword>
	<keyword>Nociceptive pain</keyword>
	<keyword>neurologic pain</keyword>
	<keyword>transdermal</keyword>
	<keyword>compound</keyword>
	<keyword>compound</keyword>
</DOC>